Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party.
about
Critical appraisal of rituximab in the maintenance treatment of advanced follicular lymphomaRole of consolidation with yttrium-90 ibritumomab tiuxetan in patients with advanced-stage follicular lymphomaFollicular lymphoma: 2014 update on diagnosis and managementThe Role of Autologous and Allogeneic Stem Cell Transplantation in Follicular Lymphoma in The New Drugs EraReappraising the timing of transplant for indolent non-Hodgkin lymphomas.Autologous hematopoietic stem cell transplantation for relapsed follicular lymphoma: safety profile and clinical outcome in a single-center experience.SEOM clinical guidelines for the treatment of follicular non-Hodgkin's lymphoma.Long-term outcomes of high dose treatment and autologous stem cell transplantation in follicular and mantle cell lymphomas - a single centre experience.Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: a European perspective.The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma.Therapeutic approaches in patients with newly diagnosed follicular lymphoma.Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.Randomized controlled trials in relapsed/refractory follicular lymphoma: a systematic review and meta-analysis.Chemotherapy and treatment algorithms for follicular lymphoma: a look at all options.Reduced-intensity allogeneic stem cell transplantation for co-emergence of chemotherapy-refractory follicular lymphoma and therapy-related myelodysplastic syndromeFrontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database.Prediction of high risk for death in patients with follicular lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in first-line chemotherapy.Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long term disease control. An analysis from the Lymphoma Working Party Of the EBMT.Follicular lymphoma: 2015 update on diagnosis and management.Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma.Transplantation in follicular lymphoma: not "yes or no" but "whom and when".Allogeneic Transplantation for Follicular Lymphoma: Does One Size Fit All?Follicular lymphoma: 2018 update on diagnosis and management.Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party.Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome.Does bendamustine impact the mobilization of peripheral blood stem cells? A multicenter retrospective study of 23 cases.PET/CT before autologous stem cell transplantation predicts outcome in refractory/relapsed follicular lymphoma.Spotlight on copanlisib and its potential in the treatment of relapsed/refractory follicular lymphoma: evidence to dateNewly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P2860
Q26775837-FAB496E5-0324-456D-A362-27D2F37CDB92Q27000310-DDE93771-18EF-4DA4-98AD-9F0755AF0313Q27021850-FCE1E6B1-D361-403D-B476-E951CFEF8F06Q28072397-EB0089BE-A5DF-43B5-BACD-2F9BF43FFD36Q30248407-C5D00938-9F4C-4FC8-9CDE-584080021927Q34459589-1B9B7BC4-9698-4A72-A8D3-AD4632D612FBQ36400279-AAF1D82A-6512-445B-AD57-9E968BD0C079Q37671462-7D335F50-9283-4AD9-B2B1-3106CDBBD7C2Q38209433-DC8FB4D3-D6C9-489C-A18D-907E3A8C5F82Q38230693-1504E735-AE60-4A20-A84B-D4D43FE0ACAFQ38267041-5EEDB59B-09C8-4274-8F52-7F28EDF06615Q38387292-F55CD2DC-63F2-4D52-BB57-46330A9B2857Q38576523-56CFAEC8-9C56-456C-8F2A-B94A82F53BBCQ38594531-7F8A8037-13D6-4849-ADDC-B8A8FBB8A8C2Q38737930-A7CF26DD-19E3-450F-86D8-0E489BC16921Q39353147-BCF11F99-C3B8-48D8-B861-2547C217F534Q39739502-85A0540C-D8C1-4DEC-952D-F50189B18A46Q39933774-7B8A8567-073C-4283-8FC9-36DC211A3802Q40122693-1F422442-4754-4BA7-A96F-7B9337A9D254Q41696221-5848DC95-FC43-41B3-B584-3BF86AB5D1FEQ42583736-E6260138-44C9-4DF8-BB16-860F6F89D1A8Q47174138-20D1A7A1-B48B-4FE0-9FC0-08D06D86F7E7Q47219215-534A19D0-A9FC-425D-B214-7093052F1C25Q48116465-404E0764-A334-4125-84A3-6D8375BB09FFQ48280234-19AB1AFA-56CB-4955-A8CC-B5FFC7B3FDB1Q52884713-6C9D2CDB-2CC6-4EFA-B0BF-A802DDA89517Q53083933-B544B7B1-9E7B-4768-9147-8907BB910427Q58785964-05780EF3-1FC1-4A02-B772-5F6ADEE63F81Q59273877-164E1EC3-CA0A-448D-B7BB-9FC467108DC6
P2860
Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Indications for hematopoietic ...... e EBMT-Lymphoma Working Party.
@en
type
label
Indications for hematopoietic ...... e EBMT-Lymphoma Working Party.
@en
prefLabel
Indications for hematopoietic ...... e EBMT-Lymphoma Working Party.
@en
P2093
P2860
P1433
P1476
Indications for hematopoietic ...... e EBMT-Lymphoma Working Party.
@en
P2093
Anna Sureda
Armando López-Guillermo
Harry C Schouten
Martin Dreyling
Michele Ghielmini
Peter Dreger
Robert E Marcus
Silvia Montoto
Stephen Mackinnon
P2860
P304
P356
10.3324/HAEMATOL.2013.084723
P577
2013-07-01T00:00:00Z